MetaCap

Oramed Pharmaceuticals Statistics

NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.57-0.12 (-3.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Oramed Pharmaceuticals by the numbers

Oramed Pharmaceuticals has a market capitalization of $155.2 million based on 43.49M shares outstanding. Its trailing P/E ratio is 1.0. The stock trades 16.1% below its 50-day average and 12.2% below its 200-day average.

Average daily trading volume is 173.38K shares, or about $618,974 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ORMP valuation vs. peer median

ORMP compared with the median of 8 peer companies
MetricORMPPeer medianDifference
Market cap$155.24M$149.81M+4%
Avg. volume173.38K712.60K-76%

Peer median across 8 companies: IFRX, ELDN, RNA, EMIS, VRXA, PRQR, BBOT, ABEO.

Valuation

Market cap
$155.24M
Price / sales (latest FY)
77.62

Price and trading

Previous close
3.69
Open
3.67
Day range
3.54 – 3.71
52-week range
2.52 – 5.47
52-week change
+38.37%
Beta
—
Volume
285.67K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
155.24M
Pe
1.05
Forward Pe
-44.63
Eps
3.41
Dividend Yield
7.00%
Dividend Rate
0.00
Week52 High
5.47
Week52 Low
2.52
Avg Volume
173.38K
Shares Outstanding
43.49M
Ma50
4.25
Ma200
4.07
Earnings Date
Nov 12, 2026
Pct From52w High
-34.73%
Pct From52w Low
41.67%

Related